Cibc Private Wealth Group, LLC Viking Therapeutics, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 1,361 shares of VKTX stock, worth $37,740. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,361
Previous 1,351
0.74%
Holding current value
$37,740
Previous $54,000
40.74%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding VKTX
# of Institutions
434Shares Held
65.3MCall Options Held
8.28MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$282 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$167 Million0.01% of portfolio
-
State Street Corp Boston, MA4.06MShares$112 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY3.13MShares$86.7 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.12MShares$86.5 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.13B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...